Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

Supplementary Table S6 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer

<p>Supplementary Table S6. Clinical response annotation of the scRNAseq dataset obtained from BCCs treated with ICI.</p>

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Christine Pich-Bavastro (16509238) (author)
Muut tekijät:	Laura Yerly (16509241) (author), Jeremy Di Domizio (16509244) (author), Stéphanie Tissot-Renaud (16509247) (author), Michel Gilliet (16509250) (author), François Kuonen (16509253) (author)
Julkaistu:	2025
Aiheet:	Cancer Tumor Biology Immuno-oncology Immunotherapy Checkpoint blockade Skin Cancers Basal-cell cancer Tumor Heterogeneity
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Supplementary Table S1 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Tekijä: Christine Pich-Bavastro (16509238)
Julkaistu: (2025)

Supplementary Table S2 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Tekijä: Christine Pich-Bavastro (16509238)
Julkaistu: (2025)

Supplementary Table S3 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Tekijä: Christine Pich-Bavastro (16509238)
Julkaistu: (2025)

Supplementary Table S4 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Tekijä: Christine Pich-Bavastro (16509238)
Julkaistu: (2025)

Supplementary Table S5 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Tekijä: Christine Pich-Bavastro (16509238)
Julkaistu: (2025)

Supplementary Table S7 from Activin A–Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer
Tekijä: Christine Pich-Bavastro (16509238)
Julkaistu: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Tekijä: Aleksandar Obradovic (7549517)
Julkaistu: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Tekijä: Aleksandar Obradovic (7549517)
Julkaistu: (2025)

Figure 1 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Figure 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Figure 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Figure 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Figure 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Figure 6 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Macros for image quantification from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Supplementary Data 2 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Supplementary Data 3 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Supplementary Data 4 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Supplementary Data 5 from ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Tekijä: Massimiliano Mellone (14959419)
Julkaistu: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
Tekijä: Anuja Sathe (15028097)
Julkaistu: (2025)

Table S1 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
Tekijä: Guillaume Davidson (14964069)
Julkaistu: (2025)

Table S2 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
Tekijä: Guillaume Davidson (14964069)
Julkaistu: (2025)

Table S3 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
Tekijä: Guillaume Davidson (14964069)
Julkaistu: (2025)

Table S4 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
Tekijä: Guillaume Davidson (14964069)
Julkaistu: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
Tekijä: Kankan Cao (16437263)
Julkaistu: (2025)

Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Tekijä: Cynthia Weigel (14963361)
Julkaistu: (2025)

Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Tekijä: Cynthia Weigel (14963361)
Julkaistu: (2025)

Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Tekijä: Cynthia Weigel (14963361)
Julkaistu: (2025)

Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Tekijä: Cynthia Weigel (14963361)
Julkaistu: (2025)

Supplementary table S5 from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
Tekijä: Penglin Pan (14959703)
Julkaistu: (2025)

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy
Tekijä: Thang Pham (19938126)
Julkaistu: (2025)

Image 5_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
Tekijä: Naohiro Wakisaka (407153)
Julkaistu: (2025)

Table 1_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.xlsx
Tekijä: Naohiro Wakisaka (407153)
Julkaistu: (2025)

Image 4_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
Tekijä: Naohiro Wakisaka (407153)
Julkaistu: (2025)

Image 2_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
Tekijä: Naohiro Wakisaka (407153)
Julkaistu: (2025)

Image 3_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
Tekijä: Naohiro Wakisaka (407153)
Julkaistu: (2025)

Image 1_Exploratory spatial transcriptomic profiling of peritumoral Th2 immune polarization in HPV-positive oropharyngeal cancer.jpeg
Tekijä: Naohiro Wakisaka (407153)
Julkaistu: (2025)

Table S2 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
Tekijä: Qiangsheng Hu (15400215)
Julkaistu: (2025)

Table S3 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
Tekijä: Qiangsheng Hu (15400215)
Julkaistu: (2025)

Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
Tekijä: Sung-Eun Lee (14855067)
Julkaistu: (2025)

Cannot write session to /tmp/vufind_sessions/sess_abq0fp2b2dbvl04bd2jitlrpik